"10.1371_journal.pone.0075351","plos one","2013-09-18T00:00:00Z","Kirsten C Verhein; Francesco G Salituro; Mark W Ledeboer; Allison D Fryer; David B Jacoby","Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon, United States of America; Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Oregon, United States of America; Vertex Pharmaceuticals, Inc., Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: KCV FGS MWL ADF DBJ. Performed the experiments: KCV. Analyzed the data: KCV. Contributed reagents/materials/analysis tools: FGS MWL. Wrote the paper: KCV ADF DBJ MWL. Designed and characterized the molecules used in this study: FGS MWL.","FGS and MWL were employed by Vertex Pharmaceuticals at the time of these studies. FGS is currently employed by Sage Therapeutics. This does not alter these authorsâ€™ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. KCV, ADF, and DBJ declare no competing interests exist.","2013","09","Kirsten C Verhein","KCV",5,FALSE,5,1,1,4,TRUE,TRUE,FALSE,0,NA,FALSE
